MedPath

Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor

Completed
Conditions
Atrial Fibrillation
Registration Number
NCT00861354
Lead Sponsor
Microlife
Brief Summary

This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

any of the following

  • age 65 or older
  • hypertension
  • diabetes mellitus
  • congestive heart failure
  • previous stroke
Exclusion Criteria
  • permanent pacemaker
  • impalantable defibrillator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of the blood pressure monitor used for detecting atrial fibrillation compared to the electrocardiogram.After final subject data is available.
Secondary Outcome Measures
NameTimeMethod
Assess subjects understanding of the use of the device for atrial fibrillation.After final subject data is available.

Trial Locations

Locations (1)

Joseph Wiesel, MD medical office

🇺🇸

Flushing, New York, United States

© Copyright 2025. All Rights Reserved by MedPath